These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
185 related articles for article (PubMed ID: 7525612)
21. Influence of cell type on the steroidogenic potential and basal cyclic AMP levels of ras-oncogene-transformed rat cells. Pan J; Roskelley CD; Auersperg N Differentiation; 1995 Jun; 58(5):321-8. PubMed ID: 7622009 [TBL] [Abstract][Full Text] [Related]
23. Involvement of cAMP and calcium in the induction of ornithine decarboxylase activity in an osteoblast cell line. van Leeuwen JP; Bos MP; Herrmann-Erlee MP J Cell Physiol; 1988 Jun; 135(3):488-94. PubMed ID: 2840435 [TBL] [Abstract][Full Text] [Related]
24. Mechanism of the impairment of the glucagon-stimulated phosphoenolpyruvate carboxykinase gene expression by interleukin-6 in rat hepatocytes: inhibition of the increase in cyclic 3',5' adenosine monophosphate and the downstream cyclic 3',5' adenosine monophosphate action. Christ B; Nath A; Jungermann K Hepatology; 1997 Jul; 26(1):73-80. PubMed ID: 9214454 [TBL] [Abstract][Full Text] [Related]
25. Translation of ODC mRNA and polyamine transport are suppressed in ras-transformed CREF cells by depleting translation initiation factor 4E. Graff JR; De Benedetti A; Olson JW; Tamez P; Casero RA; Zimmer SG Biochem Biophys Res Commun; 1997 Nov; 240(1):15-20. PubMed ID: 9367873 [TBL] [Abstract][Full Text] [Related]
26. SCH 51344 inhibits ras transformation by a novel mechanism. Kumar CC; Prorock-Rogers C; Kelly J; Dong Z; Lin JJ; Armstrong L; Kung HF; Weber MJ; Afonso A Cancer Res; 1995 Nov; 55(21):5106-17. PubMed ID: 7585559 [TBL] [Abstract][Full Text] [Related]
27. A role for protein kinase C-delta in the regulation of ornithine decarboxylase expression by oxidative stress. Otieno MA; Kensler TW Cancer Res; 2000 Aug; 60(16):4391-6. PubMed ID: 10969783 [TBL] [Abstract][Full Text] [Related]
28. Malignant transformation by H-ras results in aberrant regulation of ribonucleotide reductase gene expression by transforming growth factor-beta 1. Hurta RA; Wright JA J Cell Biochem; 1995 Mar; 57(3):543-56. PubMed ID: 7768988 [TBL] [Abstract][Full Text] [Related]
29. Elevated levels of ornithine decarboxylase cooperate with Raf/ERK activation to convert normal keratinocytes into invasive malignant cells. Hayes CS; DeFeo K; Lan L; Paul B; Sell C; Gilmour SK Oncogene; 2006 Mar; 25(10):1543-53. PubMed ID: 16278677 [TBL] [Abstract][Full Text] [Related]
30. cAMP-mediated signals as determinants for apoptosis in primary granulosa cells. Aharoni D; Dantes A; Oren M; Amsterdam A Exp Cell Res; 1995 May; 218(1):271-82. PubMed ID: 7537693 [TBL] [Abstract][Full Text] [Related]
31. Genetic evidence that a phorbol ester tumor promoter stimulates ornithine decarboxylase activity by a pathway that is independent of cyclic AMP-dependent protein kinases in CHO cells. Lichti U; Gottesman MM J Cell Physiol; 1982 Dec; 113(3):433-9. PubMed ID: 6294128 [TBL] [Abstract][Full Text] [Related]
32. ras downregulation of protein kinase C mRNA in C3H 10T1/2 fibroblasts. Fernandes ER; Ashendel CL Mol Carcinog; 1996 Sep; 17(1):23-34. PubMed ID: 8876672 [TBL] [Abstract][Full Text] [Related]
33. Requirements for and kinetics of growth arrest of neoplastic cells by confluent 10T1/2 fibroblasts induced by a specific inhibitor of cyclic adenosine 3':5'-phosphodiesterase. Bertram JS; Faletto MB Cancer Res; 1985 May; 45(5):1946-52. PubMed ID: 2985240 [TBL] [Abstract][Full Text] [Related]
34. Up-regulation of vascular endothelial growth factor/vascular permeability factor in mouse skin carcinogenesis correlates with malignant progression state and activated H-ras expression levels. Larcher F; Robles AI; Duran H; Murillas R; Quintanilla M; Cano A; Conti CJ; Jorcano JL Cancer Res; 1996 Dec; 56(23):5391-6. PubMed ID: 8968091 [TBL] [Abstract][Full Text] [Related]
36. Transformation of NIH/3T3 cells by ornithine decarboxylase overexpression. Moshier JA; Dosescu J; Skunca M; Luk GD Cancer Res; 1993 Jun; 53(11):2618-22. PubMed ID: 8495425 [TBL] [Abstract][Full Text] [Related]
37. Influence of exogenous ras and p53 on P-glycoprotein function in immortalized rodent fibroblasts. Kopnin BP; Stromskaya TP; Kondratov RV; Ossovskaya VS; Pugacheva EN; Rybalkina EY; Khokhlova OA; Chumakov PM Oncol Res; 1995; 7(6):299-306. PubMed ID: 8527864 [TBL] [Abstract][Full Text] [Related]
38. Defining the critical gene expression changes associated with expression and suppression of the tumorigenic and metastatic phenotype in Ha-ras-transformed cloned rat embryo fibroblast cells. Su ZZ; Austin VN; Zimmer SG; Fisher PB Oncogene; 1993 May; 8(5):1211-9. PubMed ID: 8479744 [TBL] [Abstract][Full Text] [Related]
39. Inhibition of ornithine decarboxylase (ODC) decreases tumor vascularization and reverses spontaneous tumors in ODC/Ras transgenic mice. Lan L; Trempus C; Gilmour SK Cancer Res; 2000 Oct; 60(20):5696-703. PubMed ID: 11059762 [TBL] [Abstract][Full Text] [Related]
40. Regulation of two forms of the TNF receptors by phorbol ester and dibutyryl cyclic adenosine 3',5'-monophosphate in human histiocytic lymphoma cell line U-937. Aggarwal BB; Graff K; Samal B; Higuchi M; Liao WS Lymphokine Cytokine Res; 1993 Jun; 12(3):149-58. PubMed ID: 7688579 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]